Effects of hydrolysis on dodecyl alcohol-modified bioactive glasses and PDLLA/modified bioactive glass composite films
Source abstract
Abstract
In this article, mesoporous 58S and 58S bioactive glasses (BGs) were surface modified by dodecyl alcohol through esterification reaction and PDLLA/modified BGs composite films were prepared. The purpose of this study was to investigate the properties of the modified BGs particles and the PDLLA/modified BGs composite films before and after hydrolytic treatment. The modified BGs powders and composite films were treated in boiling water for 20 min to remove the dodecyl chains. After hydrolytic treatment, the modified BGs powders showed increased hydrophilicity and the FTIR analysis revealed that most dodecyl chains were removed. Furthermore, the hydrophilicity of the PDLLA/modified BGs composite films was also greatly improved. The tensile strength of the composite films after hydrolysis decreased slightly, but was still much higher than that of pure PDLLA film. In addition, bone marrow mesenchymal stem cells from dogs on the composite films after hydrolytic treatment showed the highest proliferation rate. The results suggest that hydrolytic treatment is an effective and practicable method to remove alcohol chains from surface-modified BGs and polymers/modified BG composites, which may be used for preparation of bioactive scaffolds for tissue engineering applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (36)
Show source-provided references
1. Hench LL (1991) J Am Ceram Soc 74:148710.1111/j.1151-2916.1991.tb07132.x ↗
2. Hench LL, Polak JM (2002) Science 295:101410.1126/science.1067404 ↗
3. Hench LL, West KJ (1990) Chem Rev 90:3310.1021/cr00099a003 ↗
4. Saravanapavan P, Hench LL (2003) J Non-Cyst Solids 318:110.1016/S0022-3093(02)01864-1 ↗
5. Vallet-Regi M, Ragel CV, Salinas AJ (2003) Eur J Inorg Chem 102910.1002/ejic.200390134 ↗
6. Yan XX, Yu CZ, Zhou XF, Tang JW, Zhao DY (2004) Angew Chem Int Ed 43:598010.1002/anie.200460598 ↗
7. Rich J, Jaakkola T, Tirri T, Narhi T, Yli-Urpo A, Seppala J (2002) Biomaterials 23:214310.1016/S0142-9612(01)00345-3 ↗
8. Misra SK, Mohn D, Brunner TJ, Stark WJ, Philip SE, Roy I, Salih V, Knowles JC, Boccaccini AR (2008) Biomaterials 29:175010.1016/j.biomaterials.2007.12.040 ↗
9. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R (2004) Biomaterials 25:418510.1016/j.biomaterials.2003.10.082 ↗
10. Jiang G, Evans ME, Jones IA, Rudd CD, Scotchford CA, Walker GS (2005) Biomaterials 26:228110.1016/j.biomaterials.2004.07.042 ↗
11. Silva GA, Costa FJ, Coutinho OP, Radin S, Ducheyne P, Reis RL (2004) J Biomed Mater Res A 70A:44210.1002/jbm.a.30099 ↗
12. Verrier S, Blaker JJ, Maquet V, Hench LL, Boccaccini AR (2004) Biomaterials 25:301310.1016/j.biomaterials.2003.09.081 ↗
13. Lo H, Kadiyala S, Guggino SE, Leong KW (1996) J Biomed Mater Res 30:47510.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M ↗
14. Stamboulis A, Hench LL, Boccaccini AR (2002) J Mater Sci Mater Med 13:84310.1023/A:1016544211478 ↗
15. Yao J, Radin S, Leboy PS, Ducheyne P (2005) Biomaterials 26:193510.1016/j.biomaterials.2004.06.027 ↗
16. Maquet V, Boccaccini AR, Pravata L, Notingher I, Jerome R (2003) J Biomed Mater Res A 66A:33510.1002/jbm.a.10587 ↗
17. Hong ZK, Zhang PB, He CL, Qiu XY, Liu AX, Chen L, Chen XS, Jing XB (2005) Biomaterials 26:629610.1016/j.biomaterials.2005.04.018 ↗
18. Supova M (2009) J Mater Sci Mater Med 20:120110.1007/s10856-009-3696-2 ↗
19. Zhang SM, Liu J, Zhou W, Cheng L, Guo XD (2005) Curr Appl Phys 5:51610.1016/j.cap.2005.01.023 ↗
20. Cheng W, Chang J (2006) J Biomater Appl 20:36110.1177/0885328206054712 ↗
21. Borum-Nicholas L, Wilson OC (2003) Biomaterials 24:367110.1016/S0142-9612(03)00239-4 ↗
22. Liu AX, Hong ZK, Zhuang XL, Chen XS, Cui Y, Liu Y, Jing XB (2008) Acta Biomater 4:100510.1016/j.actbio.2008.02.013 ↗
23. Gao Y, Chang J (2009) J Biomater Appl 24:11910.1177/0885328208094265 ↗
24. Steele JG, McFarland C, Dalton BA, Johnson G, Evans MDM, Howlett CR, Underwood PA (1993) J Biomater Sci Polym Ed 5:24510.1163/156856293X00339 ↗
25. Ballard CC, Broge EC, McWhorter JR, Iler RK, Stjohn DS (1961) J Phys Chem 65:2010.1021/j100819a007 ↗
26. Zhong JP, Greenspan DC (2000) J Biomed Mater Res 53:69410.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6 ↗
27. Xia W, Chang J (2006) J Controlled Release 110:52210.1016/j.jconrel.2005.11.002 ↗
28. Ringe J, Kaps C, Schmitt B, Buscher K, Bartel J, Smolian H et al (2002) Cell Tissue Res 307:32110.1007/s00441-002-0525-z ↗
29. Dufrane D, Delloye C, McKay IJ, De Aza PN, De Aza S, Schneider YJ, Schultz O, Burmester GR, Haupl T, Sittinger M (2003) J Mater Sci Mater Med 14:3310.1023/A:1021545302732 ↗
30. Ossenkamp GC, Kemmitt T, Johnston JH (2002) Langmuir 18:574910.1021/la015732z ↗
31. Arcos D, Greenspan DC, Vallet-Regi M (2003) J Biomed Mater Res A 65A:34410.1002/jbm.a.10503 ↗
32. Hiroshi Utsugi HH, Matsuzawa T (1975) J Colloid Interface Sci 50:15410.1016/0021-9797(75)90262-3 ↗
33. Anselme K (2000) Biomaterials 21:66710.1016/S0142-9612(99)00242-2 ↗
34. Verrier S, Bareille R, Rovira A, Dard M, Amedee J (1996) J Mater Sci Mater Med 7:4610.1007/BF00121189 ↗
35. Yang M, Zhu SS, Chen Y, Chang ZJ, Chen GQ, Gong YD, Zhao NM, Zhang XF (2004) Biomaterials 25:136510.1016/j.biomaterials.2003.08.018 ↗
36. Webb K, Hlady V, Tresco PA (1998) J Biomed Mater Res 41:42210.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K ↗